OTCMKTS:MCUJF Medicure (MCUJF) Stock Price, News & Analysis $0.83 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About Medicure Stock (OTCMKTS:MCUJF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medicure alerts:Sign Up Key Stats Today's Range$0.83▼$0.8350-Day Range$0.71▼$0.9452-Week Range$0.44▼$0.94VolumeN/AAverage Volume540 shsMarket Capitalization$8.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs. Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors. Its commercial portfolio includes branded cardiovascular products, while its research and development pipeline features small‐molecule candidates targeting acute heart failure, pulmonary hypertension and related conditions. The company leverages its regulatory and clinical expertise to shepherd assets from late‐stage development through to market access. Since its founding in 2004, Medicure has grown by forging collaborations with both larger pharmaceutical companies and specialty distributors, aiming to accelerate product launches and maximize reach in key therapeutic segments. The senior leadership team brings decades of experience in drug development, regulatory affairs and commercial operations, positioning Medicure to advance its niche cardiovascular and critical‐care medicines to patients in need.AI Generated. May Contain Errors. Read More Receive MCUJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MCUJF Stock News HeadlinesMedicure Completes Acquisition of West Olympia PharmacyJune 17, 2025 | tipranks.comMedicure reports stable intangible assets in Q1 filingMay 23, 2025 | investing.comNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle the "New Nvidia." But is Oracle really the #1 AI stock you should buy today? | Chaikin Analytics (Ad)Medicure Inc. (MCUJF) Q4 2024 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comMedicure Inc. Reports 2024 Financial Results with Increased Revenue but Net LossApril 25, 2025 | tipranks.comMedicure Expands U.S. Pharmacy Business with West Olympia AcquisitionApril 11, 2025 | tipranks.comMedicure Completes Strategic Acquisition of Gateway Medical PharmacyMarch 11, 2025 | tipranks.comMedicure Expands Pharmacy Business with Gateway AcquisitionFebruary 18, 2025 | tipranks.comSee More Headlines MCUJF Stock Analysis - Frequently Asked Questions How have MCUJF shares performed this year? Medicure's stock was trading at $0.62 on January 1st, 2025. Since then, MCUJF stock has increased by 33.2% and is now trading at $0.8260. How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) announced its quarterly earnings data on Wednesday, August, 20th. The company reported ($0.06) earnings per share for the quarter. The firm earned $4.82 million during the quarter. Medicure had a negative net margin of 5.70% and a negative trailing twelve-month return on equity of 6.65%. How do I buy shares of Medicure? Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/20/2025Today9/15/2025Next Earnings (Estimated)11/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:MCUJF CIK1133519 Webwww.medicure.com Phone(204) 487-7412Fax204-488-9823EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$760 thousand Net Margins-5.70% Pretax Margin-4.85% Return on Equity-6.65% Return on Assets-4.52% Debt Debt-to-Equity Ratio0.03 Current Ratio1.48 Quick Ratio1.06 Sales & Book Value Annual Sales$15.99 million Price / Sales0.54 Cash Flow$0.09 per share Price / Cash Flow9.26 Book Value$1.45 per share Price / Book0.57Miscellaneous Outstanding Shares10,440,000Free Float9,090,000Market Cap$8.62 million OptionableNot Optionable Beta1.11 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:MCUJF) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.